Lastly, BCLXL is upregulated in the tumor microenvironment of both mantle cell lymphoma and follicular lymphoma53, and the tumor microenvironment is a crucial factor in determining response to immunotherapy54. The gene discussed is BCL2L1; the disease is neoplasm.